Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Consort Medical plc
Consort Medical plc
Activities:
Manufacturing
Drug Delivery
Medical Devices
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates
The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
Recipharm and Consort Medical agree takeover to integrate CDMO services
The Board of Consort has confirmed its unanimous intention to recommend a cash offer of US$652m for the acquisition
Manufacturing
Consort Medical backs Mylan in FDA approval for generic version of Advair
British CDMO has built a 5,500 sqm dedicated cleanroom at its King’s Lynn site to support production of the dry powder inhaler
Manufacturing
Consort Medical upgrades European facilities
Global CDMO invests in manufacturing and packaging capabilities for Aesica production plants in Italy and Germany
Media
Consort Medical signs agreement with Opiant Pharmaceuticals
Subsidiaries Bespak and Aesica will jointly develop, with the specialty pharmaceutical company, a ready-to-use nasal delivered version of nalmefene to treat opioid overdoses
Recruitment
CFO appointment for Consort Medical
Consort Medical announces that Paul Hayes, Group Finance Director of The Vitec Group, is to succeed Richard Cotton as Consort Medical’s Group Chief Financial Officer (CFO)
Drug Delivery
Consort Medical closes Syrina auto-injector master development agreement
Consort Medical is pleased to announce that Bespak has entered into a master development agreement including key commercial supply terms with a leading global biopharmaceutical company
Drug Delivery
Bespak signs new scale-up and commercial supply agreement
Pressurised metered dose inhaler technology will be used in respiratory devices to treat COPD
Subscribe now